390 filings
Page 12 of 20
8-K
nsq wssvlt8p
29 Mar 18
Pulmatrix Announces Pricing of $15.2 Million Underwritten Public Offering
12:00am
EFFECT
4quvbs04bl0bdtoon
28 Mar 18
Notice of effectiveness
12:00am
CORRESP
oypu9z8 fj54h5a4
28 Mar 18
Correspondence with SEC
12:00am
CORRESP
h0akdpw3d btxyjp
28 Mar 18
Correspondence with SEC
12:00am
CORRESP
koehi2w16o3 1ut
27 Mar 18
Correspondence with SEC
12:00am
FWP
2owb4 at0k
26 Mar 18
Free writing prospectus
12:00am
CORRESP
9euog7u7
26 Mar 18
Correspondence with SEC
12:00am
CORRESP
h437ynl5
26 Mar 18
Correspondence with SEC
12:00am
UPLOAD
zl5 5wuklqmj1t47
19 Mar 18
Letter from SEC
12:00am
8-K
rfx4tif3
13 Mar 18
Pulmatrix Reports 2017 Financial Results; Provides 2018 Outlook on Pulmonary Disease Pipeline
12:00am
8-K
b14fayo5jxbxeob
9 Feb 18
Regulation FD Disclosure
12:00am
8-K
77id4br8
17 Jan 18
Regulation FD Disclosure
12:00am
CT ORDER
qt8z 59u7k75b
12 Dec 17
Confidential treatment order
12:00am